BUSINESS
January 12, 2007 | Associated Press
INDIANAPOLIS -- Eli Lilly & Co. said yesterday it will halt construction of a Virginia insulin plant as part of a shift in the drug maker's focus toward biotech products. The Indianapolis company said it will stop building the Prince William County, Va., center because production can be handled by existing plants and a center being built in Italy. All 120 employees in Prince William will be given a chance to transfer or will receive severance packages. The company also will offer exit packages to 250 of the 1,000 employees at its plant in Lafayette.
NEWS
April 30, 2012 | By Deborah Kotz
While type 2 diabetes was virtually nonexistent in children nearly 30 years ago, about 4,000 new cases are now diagnosed nationally every year in those under age 20, and a study suggests the condition is much tougher to manage in teens than adults. The nationwide study involved 700 overweight children under 17 who were recently diagnosed with type 2 diabetes, including some from the Boston area. Researchers found that 46 percent of the participants treated with the drug metformin - either alone, with intensive weight-loss counseling, or in combination with another...
LIFESTYLE
March 26, 2012 | Marilynn Marchione, AP Chief Medical Writer
New research gives clear proof that weight-loss surgery can reverse and possibly cure diabetes, and doctors say the operation should be offered sooner to more people with the disease — not just as a last resort. The two studies, released on Monday, are the first to compare stomach-reducing operations to medicines alone for "diabesity" — Type 2 diabetes brought on by obesity. Millions of Americans have this and can't make enough insulin or use what they do make to process sugar from food.
BUSINESS
January 14, 2010 | Associated Press
TRENTON, N.J. - An experimental artificial pancreas will soon be tested in diabetes patients, potentially sparing them the most dangerous complications and frequent blood sugar checks and insulin injections. If all goes well, a commercial model could be on the market in four years, said Aaron Kowalski, research director of the Juvenile Diabetes Research Foundation’s artificial pancreas project. The device, being developed by the foundation and health care giant Johnson & Johnson, potentially could help about 6 million diabetics in the United...
BOSTON GLOBE
August 26, 2010 | Jeffrey Collins, Associated Press
COLUMBIA, S.C. — Dr. William R. Kirtley, a medical research pioneer who helped develop drugs that greatly improved the lives of diabetics, has died. He was 96. Jane Kirtley said her father died Sunday in a hospital near his Hilton Head Island home. Dr. Kirtley was part of a team at Eli Lilly & Co. that conducted groundbreaking research on diabetes drugs after World War II. Jane Kirtley said her father helped refine injectable insulin and develop pills to help diabetics naturally produce insulin.
BUSINESS
May 3, 2011 | Associated Press
WASHINGTON — The Food and Drug Administration has approved a new diabetes pill from Boehringer Ingelheim and Eli Lilly for patients who can’t control their blood sugar with older medicines. Tradjenta was approved for adults with type 2 diabetes, which affects 24 million people in the United States who have trouble breaking down carbohydrates because their bodies have become resistant to the protein insulin. They are at higher risk for heart attacks, kidney problems, blindness, and other serious complications.